Bank of Montreal’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-3,050
Closed -$17K 4956
2018
Q1
$17K Hold
3,050
﹤0.01% 3616
2017
Q4
$24K Sell
3,050
-14,690
-83% -$133K ﹤0.01% 3540
2017
Q3
$176K Sell
17,740
-9,170
-34% -$131K ﹤0.01% 2719
2017
Q2
$562K Buy
26,910
+2,330
+9% +$48.8K ﹤0.01% 2221
2017
Q1
$615K Buy
24,580
+24,540
+61,350% +$633K ﹤0.01% 2036
2016
Q4
$1K Buy
+40
New +$1.12K ﹤0.01% 4007

Bank of Montreal's IPCI Position: Q1 2019 in Review

Bank of Montreal sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 63 shares.

Bank of Montreal first reported a position in IPCI in Q2 2013 and held it in 23 quarters. The position peaked at $564K in Q2 2017. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.

  • Bank of Montreal reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
  • Bank of Montreal sold 63 Intellipharmaceuticals International Inc. shares in Q1 2019.
  • Bank of Montreal first reported a position in Intellipharmaceuticals International Inc. in Q2 2013 and held it in 23 quarters.
  • Bank of Montreal's Intellipharmaceuticals International Inc. position peaked at $564K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.

Based on Bank of Montreal's 13F filing for Q1 2019, filed 26 Apr 2019.